
UK Group Buys Israeli Developer Of Algae-Based Medical Solutions Sealantis For $25M
Sealantis develops innovative products based on a proprietary platform of alga-mimetic tissue adhesives, for a wide variety of applications and clinical needs in internal surgery. 
	
	February 04, 2019

